Results of the Phase III DASISION trial and the future of CML treatment
Updated analysis of Phase III trial of idelalisib combined with bendamustine and rituximab in CLL
Pharmacoeconomics of mobilization
Navigating advances in the myeloma landscape over the past couple of years
Saad Z. Usmani
Why is supportive care important in myeloma?